GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 79 filers reported holding GENMARK DIAGNOSTICS INC in Q2 2016. The put-call ratio across all filers is 1.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,328,000 | +3.8% | 108,464 | 0.0% | 0.04% | 0.0% |
| Q3 2016 | $1,279,000 | +35.6% | 108,464 | 0.0% | 0.04% | +38.5% |
| Q2 2016 | $943,000 | +65.1% | 108,464 | 0.0% | 0.03% | +85.7% |
| Q1 2016 | $571,000 | -32.3% | 108,464 | -0.1% | 0.01% | -33.3% |
| Q4 2015 | $843,000 | -1.2% | 108,572 | 0.0% | 0.02% | -16.0% |
| Q3 2015 | $853,000 | -13.3% | 108,572 | 0.0% | 0.02% | -21.9% |
| Q2 2015 | $984,000 | -30.1% | 108,572 | 0.0% | 0.03% | -42.9% |
| Q1 2015 | $1,408,000 | -4.5% | 108,572 | 0.0% | 0.06% | -1.8% |
| Q4 2014 | $1,475,000 | +51.4% | 108,572 | 0.0% | 0.06% | +16.3% |
| Q3 2014 | $974,000 | – | 108,572 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|